Mar 12 |
BioXcel Therapeutics, Inc. (BTAI) Q4 2023 Earnings Call Transcript
|
Mar 12 |
BioXcel Therapeutics GAAP EPS of -$0.76 beats by $0.15, revenue of $0.38M misses by $0.36M
|
Mar 12 |
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
|
Mar 11 |
BioXcel Therapeutics Q4 2023 Earnings Preview
|
Mar 7 |
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
|
Mar 1 |
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
|
Feb 22 |
15 Hot Penny Stocks On the Move
|
Feb 21 |
UBS cuts BioXcel to neutral; cites regulatory issues, financing
|
Feb 13 |
Why BioXcel Therapeutics Shares Are Rising Tuesday
|
Feb 13 |
BioXcel Therapeutics announces termination of proposed public offering
|